Insight ReportAI in Action: Redefining Drug Discovery Madhav Pitaliya, Analyst Sector Lead: Anand Kumar, Associate Director of Retail Research July 24, 2024 Reasons to ReadArtificial intelligence (AI) and generative AI are transforming industries worldwide, and the healthcare sector is no exception. Discover the applications and benefits of AI in revolutionizing drug discovery, and notable technology providers in the space. Companies mentioned in this report include: BenevolentAI, Exscientia, Insilico Medicine, Novo Nordisk, Pfizer, XtalPi Other relevant research: AI/XR, M.D.: Healthcare’s Tech-Enabled Future—Part One and Part Two Retail 2024: Top 10 Trends in US Healthcare Market Navigator: US Drugstore and Pharmacy Retailers—A Strong Focus on Healthcare Expansion in 2024 and Beyond Generative AI for US Retail Pharmacies and Healthcare: Satisfying Customers through Automation and Personalization AI Is Revolutionizing Healthcare: Four Applications, Countless Benefits Visit the Coresight Research Retail Technology Hub to explore reports, data and competitive landscapes on technology. Already a subscriber? Log in You are currently viewing a preview of this report. Please select an access option to view the full report. Hide Options - Show Options + Get unlimited access to all our research with one of our subscription plans. View Subscription Plans or Contact us to purchase this report. Contact us ✕ This document was generated for Other research you may be interested in: The Sentiment Split: Optimism at the Top, Strain at the Bottom; Plus, Social Commerce Shopping in Focus—US Consumer Survey InsightsTransforming Beauty Retail: AI Across the Value Chain, from Innovation to PersonalizationInnovator Profile: Chimeable—Generating Authentic Reviews and Scaling User Videos Through Social Media SyndicationEarnings Insights 4Q24, Week 3: Gucci Sales Slump 21%, Plus Updates from Ahold, Amazon, Coty and More
